Javier Gómez retweeted
Médicos de Cataluña 👨⚕️👩⚕️ (@metgescatalunya) se topa con un muro en la mediación por la #HuelgaIndefinida. Acusa 👉 a la consejería de Salud (@Salutcat) de hacer una “dejadez consciente de funciones y responsabilidades”. diariomedico.com/farmacia/pr…
Javier Gómez retweeted
📣#LoMásLeído| 🩺 #SanidadCeuta | @cesm_sindicatos critica que el @DefensorPuebloE haya cerrado su queja sobre la situación sanitaria de Ceuta sin formular recomendaciones concretas. El sindicato reclama medidas para abordar las deficiencias denunciadas
@sanidadgob @INGESAnidad
f.mtr.cool/qmyt77wp4q
Javier Gómez retweeted
"Science needs us to work on the things that everyone else doesn't work on. When doing new things, you've got to be prepared to fail fast. If something is hard, you might need the support of a mentor to decide if you should carry on with your work or if you should let it go."
- Brian Schmidt to high school students in South Korea
If you missed our event in Seoul, South Korea, watch the full event here: nobelprize.org/events/nobel-…
Javier Gómez retweeted
HELEN-Trio 011: Anthracycline-free camrelizumab + docetaxel/carboplatin improved pCR in stage II–III TNBC: 57.5% vs 45.4%.
A promising step toward de-escalation, but EFS remains immature and there was no KEYNOTE-522 comparator. @Larvol @OncoAlert
📣#LoMásLeído| 🦷 #Odontopediatría | La IV Cumbre Mundial de Odontopediatría se celebrará por primera vez en España. El Dr. Miguel Hernández (SEOP) destaca la importancia de basar las decisiones sobre ortodoncia temprana en la evidencia científica.
f.mtr.cool/l0cr5hd57i
Javier Gómez retweeted
Javier Gómez retweeted
Palex Group refuerza su presencia en Suiza con la adquisición de Vascular Medical GmbH biotech-spain.com/es/article…
Javier Gómez retweeted
Woke up today to news of flying cars but am still using the fax machine at work
The future remains tantalizingly out of reach
Javier Gómez retweeted
💊Europa recomienda la autorización del GLP-1 oral de Lilly (@EliLillyandCo) para la obesidad y la diabetes tipo 2 en adultos
elglobalfarma.com/industria/…
Javier Gómez retweeted
High-quality antibodies tailored to your needs because one size doesn’t fit all.
Rapidly discover and optimize functional antibodies.
In vivo, in vitro, and in silico all under one roof for end-to-end drug discovery solutions: twistbioscience.com/twist-bi…
Javier Gómez retweeted
Whole-Genome Diagnostics Evolve with RNA and Pangenome Integration
@AmbryGenetics' GenomeNext test uncovers rare diseases with more comprehensive sequencing, diverse genomic references, and ongoing reanalysis
#genetictesting #WGS #DNA #rarediseases
hubs.li/Q04BpK790
🦴 #Osteoporosis | @FHOEMO y @seiomm reclaman evaluar el riesgo de pérdida ósea y fracturas desde la perimenopausia para identificar precozmente a las mujeres con mayor riesgo y reforzar la prevención
@es_INE @SEMERGENap @semfyc @SEMG_ES
f.mtr.cool/7jv4bfw956
Javier Gómez retweeted
A phase 1 trial shows that treatment of patients with high-grade serous ovarian cancer with personalized neoantigen vaccines combined with PD-1 blockade was feasible and led to tumor-specific immune responses in many patients.
@DFCI_NeoVax
Javier Gómez retweeted
Early NGS in high-risk localized #ProstateCancer and Biochemical Recurrence. @CaPsurvivorship hosts a discussion between @ashleyrossmdphd @NUFeinbergMed & Matthew Smith, MD, PhD @MassGenBrigham.
🔹 Dr. Ross: Advocates for early somatic testing to facilitate clinical trial matching, prognostic stratification, and timely decision-making—noting Phase 2 data showing objective PSA responses to PARP inhibitors in BRCA-mutated biochemical relapse.
🔹 Dr. Smith: Urges caution, noting somatic mutations occur in only ~10% of treatment-naïve primary tumors and pivotal PARP data (AMPLITUDE, TALAPRO-3) stem from de novo, high-volume metastatic disease, warning against over-testing non-progressors.
Where do you stand on early genomic profiling in localized/biochemical recurrence? 💬
#WatchNow > bit.ly/46rVEt4
Javier Gómez retweeted
Hoy justo les dije a alumnos del curso de Agentes que tal vez los problemas de salud mental van a crecer mucho en los próximos meses.
Mucha gente quedará sin trabajo y sin saber qué puede aportar en el nuevo mundo que todavía no se entiende cual será.
Javier Gómez retweeted
Planning your FOG London visit this January? Add @Ardigen_SA to your exhibition floor itinerary and meet the team while connecting with the genomics and biodata community. Book your ticket: hubs.la/Q04zr8xT0
#FOG2027 #Genomics #Biodata #LifeSciences
Javier Gómez retweeted
How can large-scale omics data deliver greater research value? At FOG London this January, discover how national genomics programmes, biobanks and data infrastructure support secure sharing, federated analysis and multimodal integration. Book: hubs.la/Q04zjjgP0
#FOG2027 #Biodata #MultiOmics
Javier Gómez retweeted
Continuous research drives real progress in cancer care.
@FDA approved Tucatinib maintenance for advanced HER2+ breast cancer delayed cancer progression by a median 8.6 months in clinical trials.
#BreastCancerResearch
@UChicagoBreast @SurvivorNetTeam
ow.ly/u5x150ZXFGY
Javier Gómez retweeted
We are thrilled to announce that Insilico Medicine’s Founder and CEO, Dr. Alex Zhavoronkov, will be speaking at the Abu Dhabi Future Health Summit 2026 next week!
Join him on the Forum Stage on October 21st (11:35 – 12:15) for the highly anticipated panel: "The Future of Drug Discovery."






























